Abstract
Congestion is one of the main predictors of poor outcome in patients with heart failure (HF). Assessing and monitoring congestion is essential for optimizing HF therapy. Among the various available methods, serial measurements of estimated plasma volume (ePVS) using routine blood count and/or body weight (e.g., the Strauss, Duarte, Hakim formulas) may be useful in HF management. Further prospective study is warranted to determine whether ePVS can help optimize decongestion therapy (loop diuretics, mineralocorticoid receptor antagonists, SGLT2i) in various HF settings. This narrative review summarizes the recent evidence supporting the association of ePVS with clinical congestion and outcome(s) and discusses future directions for monitoring ePVS in HF.
Graphic abstract
Similar content being viewed by others
Abbreviations
- PV:
-
Plasma volume
- ePVS:
-
Estimated plasma volume status
- HF:
-
Heart failure
- CHF:
-
Chronic heart failure
- AHF:
-
Acute heart failure
- ADHF:
-
Acutely decompensated heart failure
- HFrEF:
-
Heart failure with reduced ejection fraction
- HFpEF:
-
Heart failure with preserved ejection fraction
- HFmrEF:
-
Heart failure with mid-range ejection fraction
References
Rubio-Gracia J, Demissei BG, Ter Maaten JM, Cleland JG, O’Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Davison BA, Givertz MM, Bloomfield DM, Dittrich H, Damman K, Perez-Calvo JI, Voors AA (2018) Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure. Int J Cardiol 258:185–191
Girerd N, Seronde MF, Coiro S, Chouihed T, Bilbault P, Braun F, Kenizou D, Maillier B, Nazeyrollas P, Roul G, Fillieux L, Abraham WT, Januzzi J Jr, Sebbag L, Zannad F, Mebazaa A, Rossignol P (2018) Ini-Crct GN and the EFHFG Integrative assessment of congestion in heart failure throughout the patient journey. JACC Heart Fail 6:273–285
Yancy CW, Jessup M, Bozkurt B, Masoudi FA, Butler J, McBride PE, Casey DE Jr, McMurray JJ, Drazner MH, Mitchell JE, Fonarow GC, Peterson PN, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL (2013) 2013 ACCF/AHA guideline for the management of heart failure: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. J Am Coll Cardiol 62:e147–e239
Miller WL (2016) Fluid volume overload and congestion in heart failure: time to reconsider pathophysiology and how volume is assessed. Circ Heart Fail 9:e002922
Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang CS, Kubo SH, Rudin-Toretsky E, Yusuf S (1990) Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure, A substudy of the studies of left ventricular dysfunction (SOLVD). Circulation 82:1724–1729
Kalra PR, Anagnostopoulos C, Bolger AP, Coats AJS, Anker SD (2002) The regulation and measurement of plasma volume in heart failure. J Am Coll Cardiol 39:1901–1908
Nijst P, Verbrugge FH, Bertrand PB, Martens P, Dupont M, Drieskens O, Penders J, Tang WH, Mullens W (2017) Plasma volume is normal but heterogeneously distributed, and true anemia is highly prevalent in patients with stable heart failure. J Card Fail 23:138–144
Kaplan E, Puestow RC, Baker LA, Kruger S (1954) Blood volume in congestive heart failure as determined with iodinated human serum albumin. Am Heart J 47:824–838
Fudim M, Hernandez AF, Felker GM (2017) Role of volume redistribution in the congestion of heart failure. J Am Heart Assoc 6:e006817
Miller WL, Mullan BP (2014) Understanding the heterogeneity in volume overload and fluid distribution in decompensated heart failure is key to optimal volume management: role for blood volume quantitation. JACC Heart Fail 2:298–305
Marenzi G, Lauri G, Grazi M, Assanelli E, Campodonico J, Agostoni P (2001) Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol 38:963–968
Testani JM, Chen J, McCauley BD, Kimmel SE, Shannon RP (2010) Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation 122:265–272
Greene SJ, Gheorghiade M, Vaduganathan M, Ambrosy AP, Mentz RJ, Subacius H, Maggioni AP, Nodari S, Konstam MA, Butler J, Filippatos G, and investigators ET (2013) Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. Eur J Heart Fail 15:1401–1411
van der Meer P, Postmus D, Ponikowski P, Cleland JG, O’Connor CM, Cotter G, Metra M, Davison BA, Givertz MM, Mansoor GA, Teerlink JR, Massie BM, Hillege HL, Voors AA (2013) The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure. J Am Coll Cardiol 61:1973–1981
Pellicori P, Shah P, Cuthbert J, Urbinati A, Zhang J, Kallvikbacka-Bennett A, Clark AL, Cleland JGF (2019) Prevalence, pattern and clinical relevance of ultrasound indices of congestion in outpatients with heart failure. Eur J Heart Fail 21:904–916
Montero D, Lundby C, Ruschitzka F, Flammer AJ (2017) True anemia-red blood cell volume deficit-in heart failure: a systematic review. Circ Heart Fail 10(5):e003610
Androne AS, Hryniewicz K, Hudaihed A, Mancini D, Lamanca J, Katz SD (2004) Relation of unrecognized hypervolemia in chronic heart failure to clinical status, hemodynamics, and patient outcomes. Am J Cardiol 93:1254–1259
Strobeck JE, Feldschuh J, Miller WL (2018) Heart failure outcomes with volume-guided management. JACC Heart Fail 6:940–948
Strauss MB, Davis RK, Rosenbaum JD, Rossmeisl EC (1951) Water diuresis produced during recumbency by the intravenous infusion of isotonic saline solution. J Clin Invest 30:862–868
Dill DB, Costill DL (1974) Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J Appl Physiol 37:247–248
Buffaloe GW, Heineken FG (1983) Plasma volume nomograms for use in therapeutic plasma exchange. Transfusion 23:355–357
Sprenger KB, Huber K, Kratz W, Henze E (1987) Nomograms for the prediction of patient’s plasma volume in plasma exchange therapy from height, weight, and hematocrit. J Clin Apher 3:185–190
Duarte K, Monnez JM, Albuisson E, Pitt B, Zannad F, Rossignol P (2015) Prognostic Value of Estimated Plasma Volume in Heart Failure. JACC Heart Fail 3:886–893
RM. H. Plasmapheresis. In: I. D. JT, B. PG and I. TS, eds (2001). Handbook of dialysis, 3rd ed Philadelphia: Lippincott. Williams and Wilkins 236
Rossignol P, Masson S, Barlera S, Girerd N, Castelnovo A, Zannad F, Clemenza F, Tognoni G, Anand IS, Cohn JN, Anker SD, Tavazzi L, Latini R, on the behalf of G-H and Val-He FTI, (2015) Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val-HeFT trials. Eur J Heart Fail 17(4):424–433
Martens P, Nijst P, Dupont M, Mullens W (2019) The optimal plasma volume status in heart failure in relation to clinical outcome. J Cardiac Failure 25(4):240–248
Dworkin HJ, Premo M, Dees S (2007) Comparison of red cell and whole blood volume as performed using both chromium-51-tagged red cells and iodine-125-tagged albumin and using I-131-tagged albumin and extrapolated red cell volume. Am J Med Sci 334:37–40
International Committee for Standardization in Haematology (1980) Recommended methods for measurement of red-cell and plasma volume: international committee for standardization in haematology. J Nuclear Med Off Publ Soc Nuclear Med 21:793–800
Molitoris BA, George AG, Murray PT, Meier D, Reilly ES, Barreto E, Sandoval RM, Rizk DV, Shaw AD, Peacock WF (2019) A novel fluorescent clinical method to rapidly quantify plasma volume. Cardiorenal Med 9:168–179
Ling HZ, Flint J, Damgaard M, Bonfils PK, Cheng AS, Aggarwal S, Velmurugan S, Mendonca M, Rashid M, Kang S, Papalia F, Weissert S, Coats CJ, Thomas M, Kuskowski M, Cohn JN, Woldman S, Anand IS, Okonko DO (2015) Calculated plasma volume status and prognosis in chronic heart failure. Eur J Heart Fail 17:35–43
Fudim M, Miller WL (2018) Calculated estimates of plasma volume in patients with chronic heart failure-comparison with measured volumes. J Cardiac Failure 24(9):553–560
Dekkers CCJ, Sjostrom CD, Greasley PJ, Cain V, Boulton DW, Heerspink HJL (2019) Effects of the sodium-glucose co-transporter-2 inhibitor dapagliflozin on estimated plasma volume in patients with type 2 diabetes. Diabet Obesity Metab 21(12):2667–2673
Yoshihisa A, Abe S, Sato Y, Watanabe S, Yokokawa T, Miura S, Misaka T, Sato T, Suzuki S, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Saitoh SI, Takeishi Y (2018) Plasma volume status predicts prognosis in patients with acute heart failure syndromes. Eur Heart J Acute Cardiovasc Care 7(4):330–338
Kataoka H (2017) Vascular expansion during worsening of heart failure: Effects on clinical features and its determinants. Int J Cardiol 230:556–561
Grodin JL, Philips S, Mullens W, Nijst P, Martens P, Fang JC, Drazner MH, Tang WHW, Pandey A (2019) Prognostic implications of plasma volume status estimates in heart failure with preserved ejection fraction: insights from TOPCAT. Eur J Heart Fail 21(5):634–642
Kobayashi M, Huttin O, Donal E, Duarte K, Hubert A, Le Breton H, Galli E, Fournet M, Mabo P, Schnell F, Leclercq C, Rossignol P, Girerd N (2020) Association of estimated plasma volume status with hemodynamic and echocardiographic parameters. Clin Res Cardiol 109(8):1060–1069
Almufleh A, Desai AS, Fay R, Ferreira JP, Buckley LF, Mehra MR, Rossignol P, Zannad F (2020) Correlation of laboratory haemoconcentration measures with filling pressures obtained via pulmonary arterial pressure sensors in ambulatory heart failure patients. Eur J Heart Fail 22(10):1907–1911
Hayasaka K, Matsue Y, Kitai T, Okumura T, Kida K, Oishi S, Akiyama E, Suzuki S, Yamamoto M, Mizukami A, Yoshioka K, Kuroda S, Kagiyama N, Yamaguchi T and Sasano T (2020) Tricuspid regurgitation pressure gradient identifies prognostically relevant worsening renal function in acute heart failure. Eur Heart J Cardiovasc Imag
Rossignol P, Menard J, Fay R, Gustafsson F, Pitt B, Zannad F (2011) Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy. J Am Coll Cardiol 58:1958–1966
Hamilton RW, Buckalew VM Jr (1984) Sodium, water, and congestive heart failure. Ann Intern Med 100:902–904
Ghali JK, Tam SW (2010) The critical link of hypervolemia and hyponatremia in heart failure and the potential role of arginine vasopressin antagonists. J Card Fail 16:419–431
Miller WL, Mullan BP (2016) Volume overload profiles in patients with preserved and reduced ejection fraction chronic heart failure: are there differences? A pilot study. JACC Heart Fail 4:453–459
Takei M, Kohsaka S, Shiraishi Y, Goda A, Izumi Y, Yagawa M, Mizuno A, Sawano M, Inohara T, Kohno T, Fukuda K, Yoshikawa T, West Tokyo Heart Failure Registry I (2015) Effect of estimated plasma volume reduction on renal function for acute heart failure differs between patients with preserved and reduced ejection fraction. Circulat Heart Failure 8:527–532
Kobayashi M, Rossignol P, Ferreira JP, Aragao I, Paku Y, Iwasaki Y, Watanabe M, Fudim M, Duarte K, Zannad F, Girerd N (2019) Prognostic value of estimated plasma volume in acute heart failure in three cohort studies. Clin Res Cardiol 108(5):549–561
Kobayashi M, Girerd N, Duarte K, Preud'homme G, Pitt B, Rossignol P (2020) Prognostic Impact of Plasma Volume Estimated from Hemoglobin and Hematocrit in Heart Failure with Preserved Ejection Fraction. Clin Res Cardiol. 109(11):1392–1401
Ergatoudes C, Schaufelberger M, Andersson B, Pivodic A, Dahlström U, Fu M (2019) Non-cardiac comorbidities and mortality in patients with heart failure with reduced vs. preserved ejection fraction: a study using the Swedish Heart Failure Registry. Clin Res Cardiol 108:1025–1033
Streng KW, Nauta JF, Hillege HL, Anker SD, Cleland JG, Dickstein K, Filippatos G, Lang CC, Metra M, Ng LL, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zwinderman AH, Zannad F, Damman K, van der Meer P, Voors AA (2018) Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction. Int J Cardiol 271:132–139
Rossignol P, Masson S, Barlera S, Girerd N, Castelnovo A, Zannad F, Clemenza F, Tognoni G, Anand IS, Cohn JN, Anker SD, Tavazzi L, Latini R, Gissi HF, Val-He FTI (2015) Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val-HeFT trials. Eur J Heart Fail 17:424–433
Huang CY, Lin TT, Wu YF, Chiang FT, Wu CK (2019) Long-term prognostic value of estimated plasma volume in heart failure with preserved ejection fraction. Sci Rep 9:14369
Balderston JR, Shah KB, Paciulli SC, Gertz ZM (2018) Usefulness of estimated plasma volume at postdischarge follow-up to predict recurrent events in patients with heart failure. Am J Cardiol 122:1191–1194
Hudson SR, Chan D, Ng LL (2016) Change in plasma volume and prognosis in acute decompensated heart failure: an observational cohort study. J R Soc Med 109:337–346
Bilchick KC, Chishinga N, Parker AM, Zhuo DX, Rosner MH, Smith LA, Mwansa H, Blackwell JN, McCullough PA, Mazimba S (2017) Plasma volume and renal function predict six-month survival after hospitalization for acute decompensated heart failure. Cardiorenal Med 8:61–70
Kobayashi M, Bercker M, Huttin O, Pierre S, Sadoul N, Bozec E, Chouihed T, Ferreira JP, Zannad F, Rossignol P, Girerd N (2020) Chest X-ray quantification of admission lung congestion as a prognostic factor in patients admitted for worsening heart failure from the ICALOR cohort study. Int J Cardiol 299:192–198
Fudim M, Lerman JB, Page C, Alhanti B, Califf RM, Ezekowitz JA, Girerd N, Grodin JL, Miller WL, Pandey A, Rossignol P, Starling RC, Tang WHW, Zannad F, Hernandez AF, O'Connor CM and Mentz RJ (2020) Plasma volume status and its association with in-hospital and post-discharge outcomes in decompensated heart failure. J Card Fail
Maznyczka AM, Barakat MF, Ussen B, Kaura A, Abu-Own H, Jouhra F, Jaumdally H, Amin-Youssef G, Nicou N, Baghai M, Deshpande R, Wendler O, Kolvekar S, Okonko DO (2019) Calculated plasma volume status and outcomes in patients undergoing coronary bypass graft surgery. Heart 105:1020–1026
Adlbrecht C, Piringer F, Resar J, Watzal V, Andreas M, Strouhal A, Hasan W, Geisler D, Weiss G, Grabenwöger M, Delle-Karth G, Mach M (2020) The impact of subclinical congestion on the outcome of patients undergoing transcatheter aortic valve implantation. Eur J Clin Invest 50:e13251
Schaefer AK, Poschner T, Andreas M, Kocher A, Laufer G, Wiedemann D, Mach M (2020) Impact of subclinical congestion on outcome of patients undergoing mitral valve surgery. Biomedicines 8(9):363
Chouihed T, Rossignol P, Bassand A, Duarte K, Kobayashi M, Jaeger D, Sadoune S, Buessler A, Nace L, Giacomin G, Hutter T, Barbe F, Salignac S, Jay N, Zannad F, Girerd N (2019) Diagnostic and prognostic value of plasma volume status at emergency department admission in dyspneic patients: results from the PARADISE cohort. Clin Res Cardiol 108(5):563–573
Testani JM, Brisco MA, Chen J, McCauley BD, Parikh CR, Tang WH (2013) Timing of hemoconcentration during treatment of acute decompensated heart failure and subsequent survival: importance of sustained decongestion. J Am Coll Cardiol 62:516–524
Parrinello G, Greene SJ, Torres D, Alderman M, Bonventre JV, Di Pasquale P, Gargani L, Nohria A, Fonarow GC, Vaduganathan M, Butler J, Paterna S, Stevenson LW, Gheorghiade M (2015) Water and sodium in heart failure: a spotlight on congestion. Heart Fail Rev 20:13–24
Davila C, Reyentovich A, Katz SD (2011) Clinical correlates of hemoconcentration during hospitalization for acute decompensated heart failure. J Card Fail 17:1018–1022
Darawsha W, Chirmicci S, Solomonica A, Wattad M, Kaplan M, Makhoul BF, Abassi ZA, Azzam ZS, Aronson D (2016) Discordance between hemoconcentration and clinical assessment of decongestion in acute heart failure. J Card Fail 22:680–688
Rao VS, Ahmad T, Brisco-Bacik MA, Bonventre JV, Wilson FP, Siew ED, Felker GM, Anstrom KK, Mahoney DD, Bart BA, Tang WHW, Velazquez EJ, Testani JM (2019) Renal effects of intensive volume removal in heart failure patients with preexisting worsening renal function. Circ Heart Fail 12:e005552
Ferreira JP, Chouihed T, Nazeyrollas P, Levy B, Seronde MF, Bilbault P, Braun F, Roul G, Kenizou D, Zannad N, Girerd N, Rossignol P (2018) Practical management of concomitant acute heart failure and worsening renal function in the emergency department. Eur J Emerg Med Off J Eur Soc Emerg Med 25:229–236
Metra M, Davison B, Bettari L, Sun H, Edwards C, Lazzarini V, Piovanelli B, Carubelli V, Bugatti S, Lombardi C, Cotter G, Dei CL (2012) Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. Circ Heart Fail 5:54–62
Damman K, Tang WH, Testani JM, McMurray JJ (2014) Terminology and definition of changes renal function in heart failure. Eur Heart J 35:3413–3416
Zannad F, Rossignol P (2018) Cardiorenal syndrome revisited. Circulation 138:929–944
Davison BA, Metra M, Cotter G, Massie BM, Cleland JGF, Dittrich HC, Edwards C, Filippatos G, Givertz MM, Greenberg B, Ponikowski P, Voors AA, O’Connor CM, Teerlink JR (2015) Worsening heart failure following admission for acute heart failure: a pooled analysis of the PROTECT and RELAX-AHF studies. JACC Heart Fail 3:395–403
Davidov M, Kakaviatos N, Finnerty FA Jr (1967) Intravenous administration of furosemide in heart failure. JAMA 200:824–829
Guazzi MD, Agostoni P, Perego B, Lauri G, Salvioni A, Giraldi F, Matturri M, Guazzi M, Marenzi G (1994) Apparent paradox of neurohumoral axis inhibition after body fluid volume depletion in patients with chronic congestive heart failure and water retention. British heart journal 72:534–539
Boyle A, Sobotka PA (2006) Redefining the therapeutic objective in decompensated heart failure: hemoconcentration as a surrogate for plasma refill rate. J Card Fail 12:247–249
Packer M, Kitzman DW (2018) Obesity-related heart failure with a preserved ejection fraction: the mechanistic rationale for combining inhibitors of aldosterone, neprilysin, and sodium-glucose cotransporter-2. JACC Heart Failure 6:633–639
Nakagawa H, Oberwinkler H, Nikolaev VO, Gaßner B, Umbenhauer S, Wagner H, Saito Y, Baba HA, Frantz S, Kuhn M (2014) Atrial natriuretic peptide locally counteracts the deleterious effects of cardiomyocyte mineralocorticoid receptor activation. Circ Heart Failure 7:814–821
McMurray JJV, Solomon SD, Inzucchi SE, Kober L, Kosiborod MN, Martinez FA et al (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 381(21):1995–2008
Rossignol P, Hernandez AF, Solomon SD, Zannad F (2019) Heart failure drug treatment. Lancet 393:1034–1044
Lambers Heerspink HJ, de Zeeuw D, Wie L, Leslie B, List J (2013) Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes. Diabetes Obes Metab 15:853–862
McMurray JJV, Solomon SD, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, Bělohlávek J, Böhm M, Chiang CE, Chopra VK, de Boer RA, Desai AS, Diez M, Drozdz J, Dukát A, Ge J, Howlett JG, Katova T, Kitakaze M, Ljungman CEA, Merkely B, Nicolau JC, O’Meara E, Petrie MC, Vinh PN, Schou M, Tereshchenko S, Verma S, Held C, DeMets DL, Docherty KF, Jhund PS, Bengtsson O, Sjöstrand M, Langkilde AM (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 381:1995–2008
Sano M, Goto S (2019) Possible mechanism of hematocrit elevation by sodium glucose cotransporter 2 inhibitors and associated beneficial renal and cardiovascular effects. Circulation 139:1985–1987
Heerspink HJL, Kosiborod M, Inzucchi SE, Cherney DZI (2018) Renoprotective effects of sodium-glucose cotransporter-2 inhibitors. Kidney Int 94:26–39
Tang WHW, Telukuntla KS, Mayuga KA (2018) Can Blood Volume Analysis-Guided Acute Heart Failure Therapy Improve Clinical Outcomes? JACC Heart Fail 6:949–950
Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, Strickland W, Neelagaru S, Raval N, Krueger S, Weiner S, Shavelle D, Jeffries B, Yadav JS (2011) Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet 377:658–666
Vaduganathan M, Greene SJ, Fonarow GC, Voors AA, Butler J, Gheorghiade M (2014) Hemoconcentration-guided diuresis in heart failure. Am J Med 127:1154–1159
Rossignol P, Fay R, Girerd N, Zannad F (2020) Daily home monitoring of potassium, creatinine, and estimated plasma volume in heart failure post-discharge. ESC Heart Failure 7:1257–1263
Okonko DO, Jouhra F, Abu-Own H, Filippatos G, Colet JC, Suki C, Mori C, Ponikowski P, Anker SD (2019) Effect of ferric carboxymaltose on calculated plasma volume status and clinical congestion: a FAIR-HF substudy. ESC Heart Fail 6:621–628
Massari F, Scicchitano P, Iacoviello M, Passantino A, Guida P, Sanasi M, Piscopo A, Romito R, Valle R, Caldarola P, Ciccone MM (2019) Multiparametric approach to congestion for predicting long-term survival in heart failure. J Cardiol 75(1):47–52
Tamaki S, Yamada T, Morita T, Furukawa Y, Iwasaki Y, Kawasaki M, Kikuchi A, Kawai T, Seo M, Abe M, Nakamura J, Yamamoto K, Kayama K, Kawahira M, Tanabe K, Ueda K, Kimura T, Sakamoto D, Fukunami M (2019) Prognostic value of calculated plasma volume status in patients admitted for acute decompensated heart failure: a prospective comparative study with other indices of plasma volume. Circ Rep 1:361–371
Author information
Authors and Affiliations
Corresponding author
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Kobayashi, M., Girerd, N., Duarte, K. et al. Estimated plasma volume status in heart failure: clinical implications and future directions. Clin Res Cardiol 110, 1159–1172 (2021). https://doi.org/10.1007/s00392-020-01794-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-020-01794-8